different configurations of the patent system upon innovation and competition. The model is able to replicate the main stylized …The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health … adverse effects in terms of innovation outcomes, as well as of market competition and consumer welfare. Such general …

an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect … witnessed by the fact that patent applications are very skewed in the covered trade names and patent thickness expands over time … pharmaceutical firms, between patent portfolio and profit margins. …

The modern law of induced patent infringement contradicts the Patent Act and violates the First Amendment. As currently … using a product in a way that is covered by a patent. This is true even when there is no evidence that prescribers read …-misleading speech for such an attenuated purpose, it also violates the First Amendment. Modern patent inducement law should be revised …

governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

. Accordingly, for this valuable subset of patents, it is paramount that the Patent & Trademark Office (PTO) correctly issue valid …, reporting the results for every Orange Book patent case that resulted in a merits decision. We find that about 25% of active …. Most litigated patents (90%) are “secondary” patents – patents on smaller tweaks to an existing drug rather than a patent …

-effects regressions, this study yields robust results. National patent protection alone does not stimulate domestic innovation, as …This paper evaluates the effects of patent protection on pharmaceutical innovations for twenty-six countries that … established pharmaceutical patent laws during 1978-2002. Controlling for country characteristics through matched sampling …

understood as being charged with sufficiently incentivizing innovation. Thus, excessively rewarding patent holders is not among … conversations about innovation incentives and fair drug pricing. To the extent states are patent preempted from regulation reaching …, however, confronts the headwinds of patent preemption. As patent rights are federally conferred, how—if at all—may states …